Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kazumi Okamura"'
Autor:
Kazumi Okamura, Lifang Wang, Satoshi Nagayama, Makiko Yamashita, Tomohiro Tate, Saki Matsumoto, Manabu Takamatsu, Shigehisa Kitano, Kazuma Kiyotani, Yusuke Nakamura
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
TCRαβ+ CD4− CD8− double-negative T (DNT) cells are minor populations in peripheral blood, and their roles have mostly been discussed in inflammation and autoimmunity. However, the functions of DNT cells in tumor microenvironment remain to be el
Externí odkaz:
https://doaj.org/article/e90401bc94a44e26b863b56cc2c0e6fd
Autor:
Ichiro Nakashima, Jin Nakahara, Hiroaki Yokote, Yasuhiro Manabe, Kazumi Okamura, Kou Hasegawa, Kazuo Fujihara
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background: The terminal complement C5 inhibitor eculizumab is approved in Japan for relapse prevention in aquaporin-4 antibody-positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD) and is undergoing mandatory post-marketing surveillance (P
Externí odkaz:
https://doaj.org/article/be2999c2978d49bba3a3526b7b8d1cc4
Autor:
Kazumi Okamura, Satoshi Nagayama, Tomohiro Tate, Hiu Ting Chan, Kazuma Kiyotani, Yusuke Nakamura
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Background Tumor-draining lymph nodes (TDLNs) are primary sites, where anti-tumor lymphocytes are primed to tumor-specific antigens and play pivotal roles in immune responses against tumors. Although adoptive cell therapy (ACT) using lymphoc
Externí odkaz:
https://doaj.org/article/faa5c078156246d4af519e154cc2a97d
Publikováno v:
Neurology. 99:S2.2-S3
ObjectiveNA.BackgroundThe terminal complement C5 inhibitor eculizumab is approved in Japan for the prevention of aquaporin-4 antibody-positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD) relapse and undergoing mandatory post-marketing surv
Publikováno v:
The Journal of Medical Investigation. 65:231-235
Several factors besides renal function influence serum cystatin C (CysC) levels. The present study evaluates the value of serum CysC and the equation for CysC based estimated glomerular filtration rate (CysC-eGFR) for Japanese children with malignanc
Autor:
Nobuki Hayashi, Yuji Ikeda, Kazumi Okamura, Tomohiro Tate, Kensaku Nemoto, Satoshi Nagayama, Yuriko Minegishi, Koji Ueda, Kazuma Kiyotani, Yusuke Nakamura, Kei Kawana
Publikováno v:
Journal of Reproductive Immunology. 148:103410
Publikováno v:
Cancer Research. 80:2148-2148
Tumor draining lymph nodes (TDLNs) are located in the routes of lymphatic drainage from a primary tumor and have the highest metastasis in various types of solid tumors. TDLNs are considered as a tissue to activate the antitumor immunity, where antig
Publikováno v:
Journal of Clinical Oncology. 38:e15180-e15180
e15180 Background: Double negative T cell (DNT) is defined by the expression of CD3 (or TCRαβ) with the absence of CD4, CD8 and iNKT cell markers. DNTs account for 1-3% of the total peripheral lymphocytes. Although healthy donor cells derived allog
Publikováno v:
Clinical and Experimental Nephrology. 19:298-308
Equations for the creatinine-based estimated glomerular filtration rate (eGFR) were recently established for Japanese adults (18 years old) and children (2-11 years old), respectively, but it is unclear whether eGFR can be as useful as 24-h creatinin
Autor:
Teruyoshi Kageji, Nami Inoue, Mika Sakaki, Kazumi Okamura, Shinji Nagahiro, Shoji Kagami, Hiroyoshi Watanabe
Publikováno v:
Child's Nervous System
Introduction Atypical teratoid rhabdoid tumor (ATRT) is a rare, highly malignant, and aggressive tumor of infancy. Although the prognosis of ATRT has been extremely poor, recently, the first prospective study for ATRT demonstrated improvement of prog